The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Startle Gating Deficits in a Large Cohort of Patients With Schizophrenia: Relationship to Medications, Symptoms, Neurocognition, and Level of Function
Abstract
CONTEXT: Patients with schizophrenia exhibit deficits in automatic, preattentive sensorimotor gating (prepulse inhibition [PPI]) of the startle reflex. OBJECTIVE: To assess the relationships between PPI deficits and demographic, clinical, neurocognitive, and functional status in a large cohort of patients with schizophrenia. DESIGN: Cross-sectional comparison of patients with schizophrenia and normal comparison subjects. SETTING: University-based psychophysiology laboratory. PARTICIPANTS: Carefully screened patients with schizophrenia (n = 103) and normal comparison subjects (n = 66). MAIN OUTCOME MEASURES: Participants were assessed in structured clinical interviews and tested in measures of acoustic startle PPI and neurocognition. The level of functioning was assessed in patients using validated scales. Analyses first compared all of the patients vs normal comparison subjects. Patients were then divided based on sex, medications, smoking status, and levels of PPI. The associations of PPI to clinical, neurocognitive, and functional variables were assessed using both continuous and categorical analyses. RESULTS: Compared with normal comparison subjects, patients exhibited PPI deficits at 60-millisecond intervals but not at 30- or 120-millisecond intervals. In addition, patients exhibited deficits in neurocognition. Among patients, PPI levels were associated with sex (higher in men than in women), medication status (highest in patients treated with atypical antipsychotics), and smoking (higher in smokers than in nonsmokers). Compared with patients in the highest quartile of PPI, those in the lowest quartile of PPI were significantly more impaired on specific functional measures but did not differ in neurocognitive measures or symptom severity. The relationship between low PPI and functional impairment was most pronounced and orderly in male patients. CONCLUSIONS: These findings highlight several important factors (sex, medications, and smoking status) that strongly impact the study and interpretation of PPI deficits in patient populations. These results also support the concept that deficient PPI is associated with impaired functional status in schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A weak tone initiates habituation of the reticular neurons’ response to a successive louder tone, leading to the phenomenon of prepulse inhibition (PPI) of the acoustic startle response (7, 8).”
From Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia (2015) · cites this paper as [7]
In the citing paper
“The deficit in PPI is most prominent in schizophrenia when the weaker tone precedes the startling sound by 60 msec (7).”
From Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia (2015) · cites this paper as [7]
Citations
Cites
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,417
Dementia Praecox or the Group of Schizophrenias
(1951) · Journal of the American Medical Association · doi:10.1001/jama.1951.02920270079043 · Cited by 4,407
Wechsler Adult Intelligence Scale-III
Ryan, J. J., & Lopez, S. J. (2001) · Springer eBooks · doi:10.1007/978-1-4615-1185-4_2 · Cited by 3,680
Structured Clinical Interview for DSM-IV Axis I Disorders
Spitzer, R. L., First, M. B., & Gibbon, M. (1997) · Medical Entomology and Zoology · Cited by 3,582
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Unconscious cerebral initiative and the role of conscious will in voluntary action
Libet, B. (1985) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00044903 · Cited by 2,623
Rethinking feelings: an fMRI study of the cognitive regulation of emotion
Ochsner, K. N., Bunge, S. A., Gross, J. J., & Gabrieli, J. D. E. (2002) · Journal of Cognitive Neuroscience · doi:10.1162/089892902760807212 · Cited by 2,520
The prefontral cortex and cognitive control
Miller, E. K. (2000) · Nature Reviews Neuroscience · doi:10.1038/35036228 · Cited by 2,016
BRAFF, D. L., Geyer, M. A., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100810 · Cited by 1,701
Self-citationGeyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Oxytocin: The Great Facilitator of Life
Lee, H.-J., Macbeth, A. H., Pagani, J., & Young, W. S. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.001 · Cited by 1,037
Neurophysiological Endophenotypes of Schizophrenia: The Viability of Selected Candidate Measures
Turetsky, B. I., Calkins, M. E., Light, G. A., D, A. O. M., Radant, A. D., & Swerdlow, N. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbl060 · Cited by 575
Self-citationRealistic expectations of prepulse inhibition in translational models for schizophrenia research
Swerdlow, N. R., Weber, M., Qu, Y., Light, G. A., & Braff, D. L. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1072-4 · Cited by 529
Self-citationLight, G. A., Hsu, J., Hsieh, M. H., Meyer-Gomes, K., Sprock, J., Swerdlow, N. R., & BRAFF, D. L. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.055 · Cited by 430
Self-citationSensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia
Javitt, D. C., & Freedman, R. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13121691 · Cited by 403
Initial Heritability Analyses of Endophenotypic Measures for Schizophrenia
Greenwood, T. A., BRAFF, D. L., Light, G. A., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Freedman, R., Green, M. F., Gur, R. E., Gur, R. C., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.11.1242 · Cited by 382
Self-citationNeurophysiological biomarkers for drug development in schizophrenia
Javitt, D. C., Spencer, K., Thaker, G. K., Winterer, G., & Hajós, M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2463 · Cited by 340
Young, J. W., Powell, S. B., Risbrough, V. B., Marston, H. M., & Geyer, M. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.02.004 · Cited by 312
Prenatal stress: Role in psychotic and depressive diseases
Markham, J. A., & Koenig, J. I. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2035-0 · Cited by 282
Top–down modulation of prepulse inhibition of the startle reflex in humans and rats
Li, L., Du, Y., Li, N., Wu, X. H., & Wu, Y. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.02.001 · Cited by 250
Quednow, B. B., Kometer, M., Geyer, M. A., & Vollenweider, F. X. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.228 · Cited by 240
Prepulse inhibition and genetic mouse models of schizophrenia
Powell, S. B., Zhou, X., & Geyer, M. A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.021 · Cited by 218
Phenotypic Landscape of Schizophrenia-Associated Genes Defines Candidates and Their Shared Functions
Thyme, S. B., Pieper, L. M., Li, E. H., Pandey, S., Wang, Y., Morris, N. S., Sha, C., Choi, J. W., Herrera, K. J., Soucy, E. R., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.048 · Cited by 220
The role of the thalamus in schizophrenia from a neuroimaging perspective
Pergola, G., Selvaggi, P., Trizio, S., Bertolino, A., & Blasi, G. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.01.013 · Cited by 203
Light, G. A., Swerdlow, N. R., & BRAFF, D. L. (2007) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2007.19.10.1624 · Cited by 188
Self-citationBrain Cannabinoid CB2 Receptor in Schizophrenia
Ishiguro, H., Horiuchi, Y., Ishikawa, M., Koga, M., Imai, K., Suzuki, Y., Morikawa, M., Inada, T., Watanabe, Y., Takahashi, M., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.024 · Cited by 188
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity
Onaivi, E. S., Ishiguro, H., Gu, S., & Liu, Q. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111400652 · Cited by 190
Mouse behavioral endophenotypes for schizophrenia
Amann, L. C., Gandal, M. J., Halene, T. B., Ehrlichman, R. S., White, S., McCarren, H. S., & Siegel, S. J. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.008 · Cited by 180
Swerdlow, N. R., BRAFF, D. L., & Geyer, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116661075 · Cited by 186
Self-citationEndophenotypes in psychiatric genetics
Walters, J., & Owen, M. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002068 · Cited by 174
Takao, K., Kobayashi, K., Hagihara, H., Ohira, K., Shoji, H., Hattori, S., Koshimizu, H., Umemori, J., Toyama, K., Nakamura, H. K., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.38 · Cited by 173
Light, G. A., & Swerdlow, N. R. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12730 · Cited by 158
Self-citationLi, Q., Cheung, C., Wei, R., Hui, E. S. K., Feldon, J., Meyer, U., Chung, S. K., Chua, S. E., Sham, P. C., Wu, E. X., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006354 · Cited by 152
Pantelis, C., Yücel, M., Bora, E., Fornito, A., Testa, R., Brewer, W. J., Velakoulis, D., & Wood, S. J. (2009) · Neuropsychology Review · doi:10.1007/s11065-009-9114-1 · Cited by 138
Impaired Sensorimotor Gating of the Acoustic Startle Response in the Prodrome of Schizophrenia
Quednow, B. B., Frommann, I., Berning, J., Kühn, K.-U., Maier, W., & Wagner, M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.019 · Cited by 135
Association Analysis of 94 Candidate Genes and Schizophrenia-Related Endophenotypes
Greenwood, T. A., Light, G. A., Swerdlow, N. R., Radant, A. D., & BRAFF, D. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029630 · Cited by 134
Self-citationGiakoumaki, S. G., Roussos, P., & Bitsios, P. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.82 · Cited by 136
Profile of auditory information-processing deficits in schizophrenia
Turetsky, B. I., Bilker, W. B., Siegel, S. J., Kohler, C. G., & Gur, R. E. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2008.04.013 · Cited by 130
Prepulse Inhibition of the Startle Reflex: A Window on the Brain in Schizophrenia
BRAFF, D. L. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_61 · Cited by 123
Self-citationGenetic Models of Sensorimotor Gating: Relevance to Neuropsychiatric Disorders
Powell, S. B., Weber, M., & Geyer, M. A. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_195 · Cited by 127
Managò, F., Mereu, M., Mastwal, S. S., Mastrogiacomo, R., Scheggia, D., Emanuele, M., Luca, M. A. D., Weinberger, D. R., Wang, K. H., & Papaleo, F. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.044 · Cited by 119
Takahashi, H., Rissling, A. J., Pascual-Marqui, R. D., Kirihara, K., Pela, M., Sprock, J., BRAFF, D. L., & Light, G. A. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.09.074 · Cited by 117
Self-citationPharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine
Ago, Y., Koda, K., Takuma, K., & Matsuda, T. (2011) · Journal of Pharmacological Sciences · doi:10.1254/jphs.11r01cr · Cited by 118
Audiovisual emotion recognition in schizophrenia: Reduced integration of facial and vocal affect
de Jong, J. J., Hodiamont, P. P. G., den Stock, J. V., & de Gelder, B. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.10.001 · Cited by 123
Shao, Z., Noh, H., Kim, W. B., Ni, P., Nguyen, C. L., Cote, S. E., Noyes, E. A., Zhao, J., Parsons, T. J., Park, J. M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0313-z · Cited by 113
Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice
Caldwell, H. K., Stephens, S. L., & Young, W. S. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002150 · Cited by 108
Sleep deprivation disrupts prepulse inhibition and induces psychosis-like symptoms in healthy humans
Petrovsky, N., Ettinger, U., Hill, A., Frenzel, L., Meyhofer, I., Wagner, M., Backhaus, J., & Kumari, V. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0904-14.2014 · Cited by 102
Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis
Swerdlow, N. R., Bhakta, S. G., Chou, H., Talledo, J., Balvaneda, B., & Light, G. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.162 · Cited by 102
Self-citationCrabtree, G. W., & Gogos, J. A. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00028 · Cited by 106
Dedic, N., Dworak, H., Zeni, C. M., Rutigliano, G., & Howes, O. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413185 · Cited by 104
Carpenter, W. T., Bustillo, J. R., Thaker, G. K., van Os, J., Krueger, R. F., & Green, M. J. (2009) · Psychological Medicine · doi:10.1017/s0033291709990286 · Cited by 99
Advances in endophenotyping schizophrenia
BRAFF, D. L., Greenwood, T. A., Swerdlow, N. R., Light, G. A., & Schork, N. J. (2008) · World Psychiatry · doi:10.1002/j.2051-5545.2008.tb00140.x · Cited by 97
Self-citationDeficient prepulse inhibition in schizophrenia detected by the multi-site COGS
Swerdlow, N. R., Light, G. A., Sprock, J., Calkins, M. E., Green, M. F., Greenwood, T. A., Gur, R. E., Gur, R. C., Lazzeroni, L. C., Nuechterlein, K. H., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2013.12.004 · Cited by 97
Self-citationBraff, D. L., Light, G. A., & Swerdlow, N. R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.015 · Cited by 90
Self-citationWegener, N., & Koch, M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.081 · Cited by 90
Hazlett, E. A., Buchsbaum, M. S., Zhang, J., Newmark, R. E., Glanton, C. F., Zelmanova, Y., Haznedar, M. M., Chu, K.-W., Nenadić, I., Kemether, E. M., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.05.039 · Cited by 90
Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms
McGregor, C., Riordan, A. J., & Thornton, J. E. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.06.003 · Cited by 90
Quednow, B. B., Ettinger, U., Mößner, R., Rujescu, D., Giegling, I., Collier, D. A., Schmechtig, A., Kühn, K.-U., Möller, H., Maier, W., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0526-11.2011 · Cited by 83
Psychophysiological Methods and Developmental Psychopathology
Zisner, A. R., & Beauchaine, T. P. (2016) · Wiley eBooks · doi:10.1002/9781119125556.devpsy222 · Cited by 84
Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?
Yang, P., Perlmutter, J. S., Benzinger, T. L. S., Morris, J. C., & Xu, J. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100994 · Cited by 83
A Upf3b-mutant mouse model with behavioral and neurogenesis defects
Huang, L., Shum, E. Y., Jones, S. H., Lou, C.-H., Chousal, J. N., Kim, H. Y., Roberts, A. J., Jolly, L. A., Espinoza, J. L., Skarbrevik, D., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.173 · Cited by 79
Self-citationMillan, M. J., Loiseau, F., Dekeyne, A., Gobert, A., Flik, G., Cremers, T. I. F. H., Rivet, J., Sicard, D., Billiras, R., & Brocco, M. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134536 · Cited by 79
San-Martin, R., Castro, L. A., Menezes, P. R., Fraga, F. J., Simões, P. W. T. D. A., & Salum, C. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa059 · Cited by 78
The mouse attentional-set-shifting task: A method for assaying successful cognitive aging?
Young, J. W., Powell, S. B., Geyer, M. A., Jeste, D. V., & Risbrough, V. B. (2010) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/cabn.10.2.243 · Cited by 78
Are we studying and treating schizophrenia correctly?
Swerdlow, N. R. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.05.004 · Cited by 78
Self-citationSensorimotor Gating is Associated with CHRNA3 Polymorphisms in Schizophrenia and Healthy Volunteers
Petrovsky, N., Quednow, B. B., Ettinger, U., Schmechtig, A., Mößner, R., Collier, D. A., Kühn, K.-U., Maier, W., Wagner, M., & Kumari, V. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.12 · Cited by 77
Wynn, J. K., Green, M. F., Sprock, J., Light, G. A., Widmark, C., Reist, C., Erhart, S. M., Marder, S. R., Mintz, J., & BRAFF, D. L. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.05.039 · Cited by 74
Self-citationBuse, J., Beste, C., Herrmann, E., & Roessner, V. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1112033 · Cited by 73
Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia
Light, G. A., Zhang, W., Joshi, Y. B., Bhakta, S. G., Talledo, J., & Swerdlow, N. R. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.81 · Cited by 73
Self-citationHe, E., Gonzalez‐Lozano, M. A., Stringer, S., Watanabe, K., Sakamoto, K., den Oudsten, F., Koopmans, F., Giamberardino, S. N., Hammerschlag, A. R., Cornelisse, L. N., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy089 · Cited by 74
Vorhees, C. V., Graham, D. L., Braun, A. A., Schaefer, T. L., Skelton, M. R., Richtand, N. M., & Williams, M. T. (2014) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2014.10.007 · Cited by 80
Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption
Echeverrı́a, V. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00173 · Cited by 73
In Vivo Ca2+ Imaging Reveals that Decreased Dendritic Excitability Drives Startle Habituation
Marsden, K. C., & Granato, M. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.060 · Cited by 72
Levin, R. R., Calzavara, M. B., Santos, C. M., Medrano, W. A., Niigaki, S. T., & Abílio, V. C. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.06.003 · Cited by 71
Hasenkamp, W. M., Epstein, M. P., Green, A. M., Wilcox, L., Boshoven, W., Lewison, B., & Duncan, E. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.11.012 · Cited by 71
Prepulse inhibition and “psychosis-proneness” in healthy individuals: An fMRI study
Kumari, V., Antonova, E., & Geyer, M. A. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2007.11.006 · Cited by 70
Roussos, P., Giakoumaki, S. G., & Bitsios, P. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.008 · Cited by 70
Swerdlow, N. R. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.09.002 · Cited by 72
Self-citationCortical grey matter volume and sensorimotor gating in schizophrenia
Kumari, V., Fannon, D. G., Geyer, M. A., Premkumar, P., Antonova, E., Simmons, A., & Kuipers, E. (2008) · Cortex · doi:10.1016/j.cortex.2007.11.007 · Cited by 67
Differentially Organized Top-Down Modulation of Prepulse Inhibition of Startle
Du, Y., Wu, X. H., & Li, L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1292-11.2011 · Cited by 66
Savonenko, A., Muñoz, P., Melnikova, T., Wang, Q., Liang, X., Breyer, R., Montine, T., Kirkwood, A., & Andreasson, K. I. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.016 · Cited by 70
The Mauthner-cell circuit of fish as a model system for startle plasticity
Medan, V., & Preuss, T. (2014) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2014.07.006 · Cited by 66
Transcription Factor SP4 Is a Susceptibility Gene for Bipolar Disorder
Zhou, X., Tang, W., Greenwood, T. A., Guo, S., He, L., Geyer, M. A., & Kelsoe, J. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005196 · Cited by 65
Brief subjective durations contract with repetition
Pariyadath, V., & Eagleman, D. M. (2008) · Journal of Vision · doi:10.1167/8.16.11 · Cited by 65
Ohira, K., Kobayashi, K., Toyama, K., Nakamura, H. K., Shoji, H., Takao, K., Takeuchi, R., Yamaguchi, S., Kataoka, M., Otsuka, S., et al. (2013) · Molecular Brain · doi:10.1186/1756-6606-6-12 · Cited by 60
Swerdlow, N. R., Light, G. A., Thomas, M. L., Sprock, J., Calkins, M. E., Green, M. F., Greenwood, T. A., Gur, R. E., Gur, R. C., Lazzeroni, L. C., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.05.013 · Cited by 65
Self-citationKuroiwa, M., Snyder, G. L., Shuto, T., Fukuda, A., Yanagawa, Y., Benavides, D. R., Nairn, A. C., Bibb, J. A., Greengard, P., & Nishi, A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2436-8 · Cited by 64
Hazlett, E. A., Romero, M. J., Haznedar, M. M., New, A. S., Goldstein, K. E., Newmark, R. E., Siever, L. J., & Buchsbaum, M. S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.03.012 · Cited by 64
An Overview of the Association between Schizotypy and Dopamine
Mohr, C., & Ettinger, U. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00184 · Cited by 63
Nicotine Effect on Prepulse Inhibition and Prepulse Facilitation in Schizophrenia Patients
Hong, L. E., Wonodi, I., Lewis, J., & Thaker, G. K. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301601 · Cited by 63
Swerdlow, N. R., Sprock, J., Light, G. A., Cadenhead, K. S., Calkins, M. E., Dobie, D. J., Freedman, R., Green, M. F., Greenwood, T. A., Gur, R. E., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.012 · Cited by 63
Self-citationHolstein, D. H., Vollenweider, F. X., Jäncke, L., Schopper, C., & Csomor, P. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.02.122 · Cited by 62
Roussos, P., Giakoumaki, S. G., Adamaki, E., & Bitsios, P. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.009 · Cited by 61
Prepulse Inhibition of Startle Response: Recent Advances in Human Studies of Psychiatric Disease
Takahashi, H., Hashimoto, R., Iwase, M., Ishii, R., Kamio, Y., & Takeda, M. (2011) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2011.9.3.102 · Cited by 61
Naert, A., Callaerts‐Vegh, Z., & D’Hooge, R. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.03.027 · Cited by 63
Translational value of startle modulations
Fendt, M., & Koch, M. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1599-5 · Cited by 63
Aggernæs, B., Glenthoj, B. Y., Ebdrup, B. H., Rasmussen, H., Lublin, H., & Oranje, B. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000787 · Cited by 59
Kask, K., Gulinello, M. E., Bäckström, T. C., Geyer, M. A., & Poromaa, I. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301599 · Cited by 61
Takahashi, H., Iwase, M., Ishii, R., Ohi, K., Fukumoto, M., Azechi, M., Ikezawa, K., Kurimoto, R., Canuet, L., Nakahachi, T., et al. (2008) · Neuroscience Research · doi:10.1016/j.neures.2008.08.006 · Cited by 59
Manning, E. E., & van den Buuse, M. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00092 · Cited by 57
Li, Q., Cheung, C., Wei, R., Cheung, V., Hui, E. S. K., You, Y., Wong, P., Chua, S. E., McAlonan, G. M., & Wu, E. X. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.015 · Cited by 57
Gogos, A., van den Buuse, M., & Rossell, S. L. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000480 · Cited by 56
Peres, F. F., Diana, M. C., Levin, R. R., Suiama, M. A., de Almeida, V., Vendramini, A. M., Santos, C. M., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. S., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00901 · Cited by 53
Cadenhead, K. S. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.04.011 · Cited by 51
Self-citationXia, Y., Zhang, Z.-Q., Lin, W.-P., Yan, J., Zhu, C., Yin, D., He, S., Su, Y., Xu, N., Caldwell, R. W., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0743-7 · Cited by 52
The Relationship of Common Risk Variants and Polygenic Risk for Schizophrenia to Sensorimotor Gating
Roussos, P., Giakoumaki, S. G., Zouraraki, C., Fullard, J. F., Karagiorga, V. E., Tsapakis, E.-M., Petraki, Z., Siever, L. J., Lencz, T., Malhotra, A. K., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.019 · Cited by 52
Reduced prepulse inhibition in adolescents at risk for psychosis: a 2-year follow-up study
Ziermans, T. B., Schothorst, P. F., Magnée, M. J. C. M., van Engeland, H., & Kemner, C. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100063 · Cited by 51
Oranje, B., & Glenthoj, B. Y. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs071 · Cited by 50
Schizophrenia endophenotypes as treatment targets
Thaker, G. K. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1189 · Cited by 50
Greenwood, T. A., Light, G. A., Swerdlow, N. R., Calkins, M. E., Green, M. F., Gur, R. E., Gur, R. C., Lazzeroni, L. C., Nuechterlein, K. H., D, A. O. M., et al. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15050605 · Cited by 49
Self-citation
Metadata
- Authors
- Swerdlow, N. R., Light, G. A., Cadenhead, K. S., Sprock, J., Hsieh, M. H., & Braff, D. L.
- Affiliations
- University of California San Diego (US)
- ORCID
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2006-12-01
- Volume
- 63
- Issue
- 12
- Pages
- 1325-35
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2169289621
- Cited by
- 339
- References
- 101
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 5 · 2023: 12 · 2022: 8 · 2021: 8 · 2020: 14 · 2019: 7 · 2018: 10 · 2017: 19 · 2016: 19 · 2015: 25 · 2014: 17 · 2013: 16 · 2012: 26
- FWCI
- 16.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R01MH069589, MH65571, MH69589, MH42228, MH 01436, MH60720, K02MH001436, R01MH060720, R01MH065571)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, prepulse inhibition, sensorimotor gating, acoustic startle response, neurocognitive function, functional disability, sex differences, atypical antipsychotics, smoking, antipsychotic effects
- MeSH terms
- Acoustic Stimulation, Adolescent, Adult, Aged, Auditory Perception, Cognition Disorders, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Neural Inhibition, Neuropsychological Tests, Psychiatric Status Rating Scales, Reaction Time, Schizophrenia, Schizophrenic Psychology, Sex Factors, Smoking, Reflex, Startle, Antipsychotic Agents, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review